124 related articles for article (PubMed ID: 1721919)
21. Expression and size heterogeneity of a 63 kilodalton membrane glycoprotein during growth and transformation of Leishmania mexicana amazonensis.
Chang CS; Inserra TJ; Kink JA; Fong D; Chang KP
Mol Biochem Parasitol; 1986 Feb; 18(2):197-210. PubMed ID: 3515177
[TBL] [Abstract][Full Text] [Related]
22. Study of Leishmania major-infected macrophages by use of lipophosphoglycan-specific monoclonal antibodies.
Handman E
Infect Immun; 1990 Jul; 58(7):2297-302. PubMed ID: 1694823
[TBL] [Abstract][Full Text] [Related]
23. NKT cell activation by Leishmania mexicana LPG: Description of a novel pathway.
Zamora-Chimal J; Fernández-Figueroa EA; Ruiz-Remigio A; Wilkins-Rodríguez AA; Delgado-Domínguez J; Salaiza-Suazo N; Gutiérrez-Kobeh L; Becker I
Immunobiology; 2017 Feb; 222(2):454-462. PubMed ID: 27523746
[TBL] [Abstract][Full Text] [Related]
24. Leishmania major-Phlebotomus duboscqi interactions: inhibition of anti-LPG antibodies and characterisation of two proteins with shared epitopes.
Tonui WK; Ngumbi PM; Mpoke SS; Orago AS; Mbati PA; Turco SJ; Mkoji GM
East Afr Med J; 2004 Feb; 81(2):97-103. PubMed ID: 15125094
[TBL] [Abstract][Full Text] [Related]
25. The heterogeneity of Leishmania cell-surface antigens.
Hernández AG; Payares G; Misle A; Dagger F
Parasitol Res; 1989; 75(8):583-8. PubMed ID: 2771925
[TBL] [Abstract][Full Text] [Related]
26. Epitope mapping of monoclonal antibodies directed against lipophosphoglycan of Leishmania major promastigotes.
Kelleher M; Curtis JM; Sacks DL; Handman E; Bacic A
Mol Biochem Parasitol; 1994 Aug; 66(2):187-200. PubMed ID: 7808469
[TBL] [Abstract][Full Text] [Related]
27. Identification of a macrophage-binding determinant on lipophosphoglycan from Leishmania major promastigotes.
Kelleher M; Bacic A; Handman E
Proc Natl Acad Sci U S A; 1992 Jan; 89(1):6-10. PubMed ID: 1370357
[TBL] [Abstract][Full Text] [Related]
28. Immunochemical characterization of a glyco-inositol-phospholipid membrane antigen of Leishmania major.
Elhay MJ; McConville MJ; Handman E
J Immunol; 1988 Aug; 141(4):1326-31. PubMed ID: 3397542
[TBL] [Abstract][Full Text] [Related]
29. Lipophosphoglycan masks recognition of the Leishmania donovani promastigote surface by human kala-azar serum.
Karp CL; Turco SJ; Sacks DL
J Immunol; 1991 Jul; 147(2):680-4. PubMed ID: 2071901
[TBL] [Abstract][Full Text] [Related]
30. Lipophosphoglycan is not required for infection of macrophages or mice by Leishmania mexicana.
Ilg T
EMBO J; 2000 May; 19(9):1953-62. PubMed ID: 10790362
[TBL] [Abstract][Full Text] [Related]
31. Lipophosphoglycan expression and virulence in ricin-resistant variants of Leishmania major.
Elhay M; Kelleher M; Bacic A; McConville MJ; Tolson DL; Pearson TW; Handman E
Mol Biochem Parasitol; 1990 May; 40(2):255-67. PubMed ID: 2362605
[TBL] [Abstract][Full Text] [Related]
32. Characterization of the species- and stage-specificity of two monoclonal antibodies against Leishmania amazonensis.
Chaves CS; Soares DC; Da Silva RP; Saraiva EM
Exp Parasitol; 2003; 103(3-4):152-9. PubMed ID: 12880592
[TBL] [Abstract][Full Text] [Related]
33. Characterization of phosphoglycan-containing secretory products of Leishmania.
Ilg T; Stierhof YD; Wiese M; McConville MJ; Overath P
Parasitology; 1994; 108 Suppl():S63-71. PubMed ID: 8084657
[TBL] [Abstract][Full Text] [Related]
34. Monoclonal antibodies specific for the amastigote stage of Leishmania pifanoi. I. Characterization of antigens associated with stage- and species-specific determinants.
Pan AA; McMahon-Pratt D
J Immunol; 1988 Apr; 140(7):2406-14. PubMed ID: 2450920
[TBL] [Abstract][Full Text] [Related]
35. Subspecies- and species-specific antigens of Leishmania mexicana characterized by monoclonal antibodies.
Pratt DM; Bennett E; Grimaldi G; Jaffe CL
J Immunol; 1985 Mar; 134(3):1935-40. PubMed ID: 2578524
[TBL] [Abstract][Full Text] [Related]
36. Structural and antigenic characterization of a species- and promastigote-specific Leishmania mexicana amazonensis membrane protein.
Kahl LP; McMahon-Pratt D
J Immunol; 1987 Mar; 138(5):1587-95. PubMed ID: 3543130
[TBL] [Abstract][Full Text] [Related]
37. Major surface protein of Toxoplasma gondii (p30) contains an immunodominant region with repetitive epitopes.
Rodriguez C; Afchain D; Capron A; Dissous C; Santoro F
Eur J Immunol; 1985 Jul; 15(7):747-9. PubMed ID: 2408905
[TBL] [Abstract][Full Text] [Related]
38. Subcellular and taxonomic specificity of monoclonal antibodies to New World Leishmania.
Anthony RL; Williams KM; Sacci JB; Rubin DC
Am J Trop Med Hyg; 1985 Nov; 34(6):1085-94. PubMed ID: 2422966
[TBL] [Abstract][Full Text] [Related]
39. Biosynthesis of lipophosphoglycan from Leishmania donovani: characterization of mannosylphosphate transfer in vitro.
Carver MA; Turco SJ
Arch Biochem Biophys; 1992 Jun; 295(2):309-17. PubMed ID: 1586160
[TBL] [Abstract][Full Text] [Related]
40. Structure and antigenicity of the lipophosphoglycan from Leishmania major amastigotes.
Moody SF; Handman E; Bacic A
Glycobiology; 1991 Sep; 1(4):419-24. PubMed ID: 1820201
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
